Morphine sulfate 15 MG Oral Tablet — RxCUI 892582
RxNorm drug concept · Semantic clinical drug
RxCUI 892582
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI892582
Official nameMorphine sulfate 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asMS 15 MG Oral Tablet
FDA products mapped12
Package NDCs mapped18
Reported Medicaid activity (SDUD)76,058 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Morphine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Morphine injection is used to relieve severe pain — the kind that hasn't responded well enough to other treatments. It's not used for mild or moderate pain. Depending on the produc...
- What is morphine injection actually used for?
- When morphine is given near your spinal cord — either in the epidural space or directly into the spinal fluid — it can cause your breathing to slow down dangerously, even hours aft...
- Why do I have to be watched so closely after getting the epidural or spinal version?
🕸️ Concept Web — How Morphine sulfate 15 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Morphine sulfate 15 MG Oral Tablet
RxCUI 892582 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Morphine
7052IN -
Morphine sulfate
30236PIN
-
Morphine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Morphine Oral Tablet
372959SCDF -
Morphine sulfate Oral Tablet
2648563SCDFP -
Morphine Oral Product
1156363SCDG -
Morphine Pill
1156364SCDG -
Morphine sulfate Oral Product
2661613SCDGP -
Morphine sulfate Pill
2661827SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Morphine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Morphine sulfate 15 MG
891877SCDC
-
Morphine sulfate 15 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Morphine sulfate 15 MG
SCDC · 891877 -
Morphine Oral Tablet
SCDF · 372959 -
Morphine sulfate Oral Tablet
SCDFP · 2648563 -
Morphine Oral Product
SCDG · 1156363 -
Morphine Pill
SCDG · 1156364 -
Morphine sulfate Oral Product
SCDGP · 2661613 -
Morphine sulfate Pill
SCDGP · 2661827
📦 FDA Products & Package NDCs
12 products · 18 package NDCs
18 package NDCs map to RxCUI 892582 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0235-24 | 100 BLISTER PACK in 1 CARTON (0054-0235-24) / 1 TABLET in 1... | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2008-03-17 |
| 00054-0235-25 | 100 TABLET in 1 BOTTLE (0054-0235-25) | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2008-03-17 |
| 00054-0236-24 | 100 BLISTER PACK in 1 CARTON (0054-0236-24) / 1 TABLET in 1... | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2008-03-17 |
| 00054-0236-25 | 100 TABLET in 1 BOTTLE (0054-0236-25) | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2008-03-17 |
| 00406-5118-01 | 100 TABLET in 1 BOTTLE (0406-5118-01) | Morphine Sulfate | SpecGx LLC | 2023-09-01 |
| 00406-5118-62 | 10 BLISTER PACK in 1 CARTON (0406-5118-62) / 10 TABLET in 1... | Morphine Sulfate | SpecGx LLC | 2023-09-01 |
| 00406-5119-01 | 100 TABLET in 1 BOTTLE (0406-5119-01) | Morphine Sulfate | SpecGx LLC | 2023-09-01 |
| 00406-5119-62 | 10 BLISTER PACK in 1 CARTON (0406-5119-62) / 10 TABLET in 1... | Morphine Sulfate | SpecGx LLC | 2023-09-01 |
| 00832-0273-11 | 100 TABLET in 1 BOTTLE (0832-0273-11) | Morphine Sulfate | Upsher-Smith Laboratories, LLC | 2019-07-22 |
| 00832-0274-11 | 100 TABLET in 1 BOTTLE (0832-0274-11) | Morphine Sulfate | Upsher-Smith Laboratories, LLC | 2019-07-22 |
| 60687-0617-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-617-01) / 1 TAB... | Morphine Sulfate | American Health Packaging | 2021-10-18 |
| 63629-8459-01 | 100 TABLET in 1 BOTTLE (63629-8459-1) | MORPHINE SULFATE | Bryant Ranch Prepack | 2025-06-16 |
| 67296-1753-01 | 10 TABLET in 1 BOTTLE (67296-1753-1) | Morphine Sulfate | RedPharm Drug, Inc. | 2019-07-22 |
| 67296-1753-06 | 6 TABLET in 1 BOTTLE (67296-1753-6) | Morphine Sulfate | RedPharm Drug, Inc. | 2019-07-22 |
| 67296-1753-07 | 12 TABLET in 1 BOTTLE (67296-1753-7) | Morphine Sulfate | RedPharm Drug, Inc. | 2019-07-22 |
| 67296-2122-06 | 6 TABLET in 1 BOTTLE (67296-2122-6) | Morphine Sulfate | Redpharm Drug | 2023-09-01 |
| 67877-0670-01 | 100 TABLET in 1 BOTTLE (67877-670-01) | MORPHINE SULFATE | Ascend Laboratories, LLC | 2021-02-11 |
| 67877-0671-01 | 100 TABLET in 1 BOTTLE (67877-671-01) | MORPHINE SULFATE | Ascend Laboratories, LLC | 2021-02-11 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (4) ·
SpecGx LLC (4) ·
RedPharm Drug, Inc. (3) ·
Ascend Laboratories, LLC (2) ·
Upsher-Smith Laboratories, LLC (2) ·
American Health Packaging (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.